A forum for researchers, students and applicants in the field of cyclodextrin technology
US patent application US2022409653 entitled “METHOD FOR PREVENTING ENTRY AND REPLICATION OF ENVELOPED VIRUSES” descibes a method for the reduction
In a recent study posted to the bioRxiv* preprint server, researchers identified β-cyclodextrins (β-CDs) as a safe and cost-effective drug
Gilead has conducted an analysis of genetic information currently available for the Omicron variant and found no additional prevalent mutations
In May, 2020, CycloLab announced a collaboration, where University of California, Berkeley, Excivion and CycloLab teamed-up to evaluate the antiviral
News Release on 23-Sep-2020 on Eurokalert Researchers at the University of Alberta have discovered a novel, second mechanism of action
Pfizer has agreed to manufacture and supply Gilead Sciences’ antiviral drug remdesivir, the pharmaceutical giant announced Friday. The multiyear agreement will support efforts to
The world’s largest cyclodextrin producer, Wacker Chemie has recently published a press release on cyclodextrins and their role in the
Bloombergs Businessweek published the story on how Gilead scineces prepared for the recently obtained emergency approval of the antiviral drug
Gilead has signed non-exclusive voluntary licensing agreements with five generic pharmaceutical manufacturers based in India and Pakistan to further expand
UC Berkeley, Excivion and Cyclolab announce a supplemental grant awarded to UC Berkeley by the National Institutes of Health to evaluate a wide
